<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:ali="http://www.niso.org/schemas/ali/1.0" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">An Bras Dermatol</journal-id>
      <journal-id journal-id-type="iso-abbrev">An Bras Dermatol</journal-id>
      <journal-id journal-id-type="publisher-id">abd</journal-id>
      <journal-title-group>
        <journal-title>Anais Brasileiros de Dermatologia</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0365-0596</issn>
      <issn pub-type="epub">1806-4841</issn>
      <publisher>
        <publisher-name>Sociedade Brasileira de Dermatologia</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">26560223</article-id>
      <article-id pub-id-type="pmc">4631243</article-id>
      <article-id pub-id-type="doi">10.1590/abd1806-4841.20153394</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Amantadine-induced livedo reticularis - Case report<xref ref-type="fn" rid="fn01">*</xref></article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Quaresma</surname>
            <given-names>Maria Vict&#xF3;ria</given-names>
          </name>
          <xref ref-type="aff" rid="aff01">1</xref>
          <xref ref-type="corresp" rid="c01"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Gomes</surname>
            <given-names>Ana Carolina Dias</given-names>
          </name>
          <xref ref-type="aff" rid="aff02">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Serruya</surname>
            <given-names>Aline</given-names>
          </name>
          <xref ref-type="aff" rid="aff01">1</xref>
          <xref ref-type="aff" rid="aff03">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Vendramini</surname>
            <given-names>D&#xE2;mia Leal</given-names>
          </name>
          <xref ref-type="aff" rid="aff01">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Braga</surname>
            <given-names>Lara</given-names>
          </name>
          <xref ref-type="aff" rid="aff01">1</xref>
          <xref ref-type="aff" rid="aff03">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Bu&#xE7;ard</surname>
            <given-names>Alice Mota</given-names>
          </name>
          <xref ref-type="aff" rid="aff01">1</xref>
        </contrib>
      </contrib-group>
      <aff id="aff01"><label>1</label>Instituto de Dermatologia Professor Rubem David Azulay -
Santa Casa da Miseric&#xF3;rdia do Rio de Janeiro &#x2013; Rio de Janeiro (RJ), Brazil.</aff>
      <aff id="aff02"><label>2</label>Universidade Federal do Rio de Janeiro (UFRJ) &#x2013; Rio de
Janeiro (RJ), Brazil.</aff>
      <aff id="aff03"><label>3</label>Funda&#xE7;&#xE3;o T&#xE9;cnico-Educacional Souza Marques (FTESM) - Rio de
Janeiro (RJ), Brazil.</aff>
      <author-notes>
        <corresp id="c01">MAILING ADDRESS: Maria Vict&#xF3;ria Quaresma, Alameda Itu, 1030, 9 B -
Jardim Paulista, 01421-001 - S&#xE3;o Paulo - SP, Brasil. E-mail:
<email>mavi@mavictoria.com.br</email></corresp>
      </author-notes>
      <pub-date pub-type="epub-ppub">
        <season>Sep-Oct</season>
        <year>2015</year>
      </pub-date>
      <!--Fake ppub date generated by PMC from publisher
							pub-date/@pub-type='epub-ppub' -->
      <pub-date pub-type="ppub">
        <season>Sep-Oct</season>
        <year>2015</year>
      </pub-date>
      <volume>90</volume>
      <issue>5</issue>
      <fpage>745</fpage>
      <lpage>747</lpage>
      <history>
        <date date-type="received">
          <day>22</day>
          <month>1</month>
          <year>2014</year>
        </date>
        <date date-type="accepted">
          <day>18</day>
          <month>2</month>
          <year>2014</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; 2015 by Anais Brasileiros de Dermatologia</copyright-statement>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/4.0/">
          <license-p>This is an Open Access article distributed under the terms of the Creative
Commons Attribution Non-Commercial License which permits unrestricted
non-commercial use, distribution, and reproduction in any medium, provided the
original work is properly cited.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>Livedo reticularis is a spastic-anatomical condition of the small vessels which
translates morphologically by a reticular pattern, interspersing cyanosis, pallor and
erythema. The same can be congenital or acquired. Among the acquired, we highlight
the physiological livedo reticularis and the idiopathic livedo by vasospasm; the
latter configures the most common cause. The drug-induced type is less common. The
drugs amantadine and norepinephrine are often implicated. Cyanosis is usually
reversible if the causative factor is removed, however, with chronicity, the vessels
may become permanently dilated and telangiectatic. We report a case of a patient
diagnosed with Parkinson&#x2019;s disease with chronic livedo reticularis associated with
the use of amantadine and improvement after discontinuation of the drug.</p>
      </abstract>
      <kwd-group>
        <kwd>Amantadine</kwd>
        <kwd>Livedo reticularis</kwd>
        <kwd>Vascular diseases</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec sec-type="intro">
      <title>INTRODUCTION</title>
      <p>Livedo reticularis (LR) should be considered an elementary dermatological lesion,
grouped within vascular macules, representing a fi nding of common dermatological
clinical examination.<sup><xref rid="r01" ref-type="bibr">1</xref></sup> The term
'livedo', first suggested by Hebra to describe a purplish discoloration of the skin
caused by an abnormality in the cutaneous circulation.<sup><xref rid="r02" ref-type="bibr">2</xref></sup></p>
      <p>LR a physiological, vasospastic response of cutaneous microvasculature to cold or
systemic disease. It is believed that the blood supply of normal skin is arranged in
cones or hexagons, whose apex is composed of the cutaneous arteriole, based on the skin
territory with a 1 cm by 4 cm area, depending on its blood irrigation. Situations where
there is reduction of the circulatory flux of these arterioles or of venous drainage may
lead to clinical appearance of LR.<sup><xref rid="r03" ref-type="bibr">3</xref>,<xref rid="r04" ref-type="bibr">4</xref></sup></p>
      <p>Erythematous-cyanotic well defined spots, called complete or closed are clinically
observed, delimiting internal skin areas with normal aspect or pale in color.<sup><xref rid="r01" ref-type="bibr">1</xref>,<xref rid="r03" ref-type="bibr">3</xref>,<xref rid="r04" ref-type="bibr">4</xref></sup></p>
      <p>Semiologically, it is fundamental to know the difference from livedo racemosa,
characteristically showing poorly defined slim and open lesions. This should direct
clinical reasoning to pathological causes.<sup><xref rid="r04" ref-type="bibr">4</xref></sup></p>
      <p>LR is benign in most cases; however, it may be secondary to different disorders,
especially in persistent cases. Vascular, rheumatological, endocrine or even infectious
diseases are listed as possible causes, besides conditions that lead to blood
hyperviscosity. Finally, certain rugs may be responsible for a LR clinical picture
(<xref ref-type="table" rid="t01">Chart 1</xref>).<sup><xref rid="r03" ref-type="bibr">3</xref></sup></p>
      <table-wrap id="t01" orientation="portrait" position="float">
        <label>Chart 1</label>
        <caption>
          <p>Main causes of livedo reticularis</p>
        </caption>
        <table frame="box" rules="groups">
          <tbody>
            <tr>
              <td align="left" rowspan="1" colspan="1">
                <bold>Congenital Livedo Reticularis:</bold>
              </td>
              <td align="left" rowspan="1" colspan="1">Cutis marmorata telangiectatica congenita</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">
                <bold>Acquired Livedo Reticularis:</bold>
              </td>
              <td align="left" rowspan="1" colspan="1">&#xA0;</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">- Vasospasms:</td>
              <td align="left" rowspan="1" colspan="1">Primary livedo reticularis, collagenosis, Raynaud's
disease.</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">- Reduction of flux:</td>
              <td align="left" rowspan="1" colspan="1">Thrombocythemia, policythemia vera, cryoglobulinemia, cryofi
brinogenemia, cold agglutinin , paraproteinaemia, antiphospholipid syndrome,
defi ciency of S and C proteins, antithrombin III, mutation of V Leiden
factor, homocystinuria, hyperhomocysteinemia; disseminated intravascular
coagulation, thrombotic thrombocytopenic purpura</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">- Pathology of vascular wall:</td>
              <td align="left" rowspan="1" colspan="1">Polyarteritis nodosa, cryoglobulinemic vasculitis, vasculitis
associated with autoimmune diseases, calciphylaxis, Sneddon's Syndrome,
livedoid vasculopathy.</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">- Vascular obstruction:</td>
              <td align="left" rowspan="1" colspan="1">Cholesterol piston, septic; atrial myxoma, trombosis,
hyperoxaluria</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">- Infections:</td>
              <td align="left" rowspan="1" colspan="1">Hepatitis C, <italic>Mycoplasma pneumoniae</italic>,
Syphilis.</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">- Medications:</td>
              <td align="left" rowspan="1" colspan="1">Noradrenaline, Interferon, Amantadine.</td>
            </tr>
          </tbody>
        </table>
      </table-wrap>
      <p>We report the clinical case of a patient with Parkinson's disease, presenting chronic,
persistent LR, associated with the use of antiparkinson medication.</p>
    </sec>
    <sec>
      <title>CASE REPORT</title>
      <p>A male, 79-year-old patient mentioned the onset of erythematous-bluish lesions of lacy
aspect, predominantly on the lower limbs, aggravated by cold weather, for around three
years. He denied local or systemic symptoms. Hypertensive, he was medicated with
propranolol. He had a cerebral vascular accident 13 years ago. A Parkinson' disease
patient, he uses amantadine in association with carbidopa and levodopa.</p>
      <p>During physical examination were observed linear maculous lesions of erythematous-bluish
color and lacy aspect on the lower limbs. No ulcerated lesions were evident, nor signs
of atrophic scars (<xref ref-type="fig" rid="f01">Figures 1</xref> and <xref ref-type="fig" rid="f02">2</xref>).</p>
      <fig id="f01" orientation="portrait" position="float">
        <label>FIGURE 1</label>
        <caption>
          <p>Livedo reticularis. Linear maculous lesions of erythematous-bluish color and lacy
aspect on lower limbs</p>
        </caption>
        <graphic xlink:href="abd-90-05-0745-g01"/>
      </fig>
      <fig id="f02" orientation="portrait" position="float">
        <label>FIGURE 2</label>
        <caption>
          <p>Livedo reticularis. Detail showing the lacy aspect</p>
        </caption>
        <graphic xlink:href="abd-90-05-0745-g02"/>
      </fig>
      <p>The laboratory investigation included a complete blood count, antinuclear factor (ANF),
C3, C4, ENA profile, VDRL, rheumatoid factor, lupus anticoagulant, total proteins and
fractions, TGO, TGP, VHS and serologies for hepatitis B and C, chest radiograph and EAS,
without alterations.</p>
      <p>The hypothesis of LR associated with the use of amantadine was considered and the
patient was referred for neurological evaluation; the medication was suspended. Two
months after the suspension, the patient did not present dermatological lesions anymore
(<xref ref-type="fig" rid="f03">Figure 3</xref>).</p>
      <fig id="f03" orientation="portrait" position="float">
        <label>FIGURE 3</label>
        <caption>
          <p>Two months after interruption of treatment with amantadine, the patient did not
present livedo reticularis</p>
        </caption>
        <graphic xlink:href="abd-90-05-0745-g03"/>
      </fig>
    </sec>
    <sec sec-type="discussion">
      <title>DISCUSSION</title>
      <p>The etiological investigation of LR involves a detailed anamnesis with information
regarding the use of medication, time of onset, associated symptoms, current diseases
and recent surgeries. This physical examination is extremely important, as well as
laboratory tests and histopathological examination that may suggest the etiology. LR is
an adverse effect commonly described in patients using amantadine for treatment of
Parkinson's disease, with preference for the female gender and involving mainly the
trunk and lower limbs.<sup><xref rid="r05" ref-type="bibr">5</xref></sup> The
differential diagnosis with livedo racemosa, with a pattern of irregular and incomplete
circles and generalized involvement, should be considered. This is normally pathological
and results from the local and persistent blood flow impediment, as by arteriosclerosis
and Sneddon's syndrome.<sup><xref rid="r04" ref-type="bibr">4</xref>,<xref rid="r06" ref-type="bibr">6</xref></sup> Any case of livedo racemosa needs
neurological investigation.</p>
      <p>The skin is irrigated by arteries that are divided into arterioles at the junction of
dermis and subcutaneous cellular tissue, forming the deep vascular plexus, which is
parallel to the epidermis<sup><xref rid="r01" ref-type="bibr">1</xref></sup>. Arterioles
emerge from this plexus and run perpendicularly to the epidermis, dividing into
capillaries near the cutaneous surface, where they form the superficial vascular
plexus.<sup><xref rid="r03" ref-type="bibr">3</xref>,<xref rid="r05" ref-type="bibr">5</xref></sup> A reduction in the volume of blood running in these
arterioles may lead to LR.</p>
      <p>Amantadine is one of the best known drugs that cause LR. Used at first as antiviral
agent, today it is more commonly used in Parkinson's disease.<sup><xref rid="r07" ref-type="bibr">7</xref></sup> It is an adamantine derivative that stimulates
norepinephrine and dopamine release into the synaptic cleft.<sup><xref rid="r05" ref-type="bibr">5</xref></sup> This drug has a anticholinergic effect and blocks
N-methyl-D-aspartate (NMDA) receptors.<sup><xref rid="r08" ref-type="bibr">8</xref></sup> The physiopathology of LR stimulated by this drug is still not fully
known, up to 40% of patients will present it.<sup><xref rid="r03" ref-type="bibr">3</xref>,<xref rid="r08" ref-type="bibr">8</xref></sup></p>
      <p>The amantadine-induced LR pattern suggests generalized cutaneous vascular alteration by
the impact on arteries and arterioles of the dermis, corroborated by the absence of
systemic involvement during the treatment.<sup><xref rid="r05" ref-type="bibr">5</xref></sup> It is a reversible side effect, with a variable clinical course (1 to
48 months). <sup><xref rid="r05" ref-type="bibr">5</xref></sup> Progression to
ulceration is possible, but is usually rapidly resolved by withdrawing the drug. As
amantadine signifi cantly improves the neurological symptoms, especially dyskinesias
derived from the use of levodopa, some patients opt for living with LR, which, except
for the cutaneous manifestation, is asymptomatic.<sup><xref rid="r05" ref-type="bibr">5</xref></sup></p>
      <p>LR histopathology will depend on the basic cause. In the physiological or idiopathic
forms, resulting from vasospasm, no alteration was found. When associated with a drug,
the histopathological lesion examination usually shows absence of vasculitis and
epidermis without alterations; is is not critical for diagnosis.<sup><xref rid="r04" ref-type="bibr">4</xref>,<xref rid="r05" ref-type="bibr">5</xref>,<xref rid="r06" ref-type="bibr">6</xref>,<xref rid="r09" ref-type="bibr">9</xref></sup></p>
      <p>It is important to call attention to this side effect of amantadine, as this association
is not always noticed by doctors and this drug is frequently prescribed in the treatment
of Parkinson's disease.</p>
    </sec>
  </body>
  <back>
    <fn-group>
      <fn fn-type="conflict">
        <p>Conflict of Interest: None.</p>
      </fn>
      <fn fn-type="supported-by">
        <p>Financial Support: None.</p>
      </fn>
      <fn fn-type="other">
        <p><bold>How to cite this article:</bold> Quaresma MV, Gomes-Dias AC, Serruya A,
Vendramini DL, Braga L, Bu&#xE7;ard-Mota A. Amantadine-induced livedo reticularis: a case
report . An Bras Dermatol. 2015;90(5):745-7.</p>
      </fn>
      <fn fn-type="other" id="fn01">
        <label>*</label>
        <p>Study carried out at the Instituto de Dermatologia Professor Rubem David Azulay -
Santa Casa da Miseric&#xF3;rdia do Rio de Janeiro &#x2013; Rio de Janeiro (RJ), Brazil.</p>
      </fn>
    </fn-group>
    <ref-list>
      <title>REFERENCES</title>
      <ref id="r01">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Herrero</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Guilabert</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Mascar&#xF3;-Galy</surname>
              <given-names>JM</given-names>
            </name>
          </person-group>
          <article-title>Diagnosis and treatment of livedo reticularis on the
legs</article-title>
          <source>Actas Dermosifiliogr</source>
          <year>2008</year>
          <volume>99</volume>
          <fpage>598</fpage>
          <lpage>607</lpage>
          <pub-id pub-id-type="pmid">19080891</pub-id>
        </element-citation>
      </ref>
      <ref id="r02">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fleischer</surname>
              <given-names>AB</given-names>
              <suffix>Jr</suffix>
            </name>
            <name>
              <surname>Resnick</surname>
              <given-names>SD</given-names>
            </name>
          </person-group>
          <article-title>Livedo reticularis</article-title>
          <source>Dermatol Clin</source>
          <year>1990</year>
          <volume>8</volume>
          <fpage>347</fpage>
          <lpage>354</lpage>
          <pub-id pub-id-type="pmid">2191805</pub-id>
        </element-citation>
      </ref>
      <ref id="r03">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gibbs</surname>
              <given-names>MB</given-names>
            </name>
            <name>
              <surname>English</surname>
              <given-names>JC 3rd</given-names>
            </name>
            <name>
              <surname>Zirwas</surname>
              <given-names>MJ</given-names>
            </name>
          </person-group>
          <article-title>Livedo reticularis: An update</article-title>
          <source>J Am Acad Dermatol</source>
          <year>2005</year>
          <volume>52</volume>
          <fpage>1009</fpage>
          <lpage>1019</lpage>
          <pub-id pub-id-type="pmid">15928620</pub-id>
        </element-citation>
      </ref>
      <ref id="r04">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kraemer</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Linden</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Berlit</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <article-title>The Spectrum Of Differential Diagnosis In Neurological Patients With
Livedo Reticularis And Livedo Racemosa - A Literature Review</article-title>
          <source>J Neurol</source>
          <year>2005</year>
          <volume>252</volume>
          <fpage>1155</fpage>
          <lpage>1166</lpage>
          <pub-id pub-id-type="pmid">16133722</pub-id>
        </element-citation>
      </ref>
      <ref id="r05">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Silva</surname>
              <given-names>SB</given-names>
            </name>
            <name>
              <surname>Miot</surname>
              <given-names>HA</given-names>
            </name>
          </person-group>
          <article-title>Case for diagnosis</article-title>
          <source>An Bras Dermatol</source>
          <year>2012</year>
          <volume>87</volume>
          <fpage>319</fpage>
          <lpage>321</lpage>
          <pub-id pub-id-type="pmid">22570045</pub-id>
        </element-citation>
      </ref>
      <ref id="r06">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Criado</surname>
              <given-names>PR</given-names>
            </name>
            <name>
              <surname>Faillace</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Magalh&#xE3;es</surname>
              <given-names>LS</given-names>
            </name>
            <name>
              <surname>Brito</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Carvalho</surname>
              <given-names>JF</given-names>
            </name>
          </person-group>
          <article-title>Livedo reticular: Classifica&#xE7;&#xE3;o, causas e diagn&#xF3;sticos
diferenciais</article-title>
          <source>Acta Reumatol Port</source>
          <year>2012</year>
          <volume>37</volume>
          <fpage>218</fpage>
          <lpage>225</lpage>
          <pub-id pub-id-type="pmid">23348110</pub-id>
        </element-citation>
      </ref>
      <ref id="r07">
        <label>7</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pinto</surname>
              <given-names>RASR</given-names>
            </name>
          </person-group>
          <article-title>Efic&#xE1;cia da amantadina no controle da discenisia tardia causada pelos
antipsic&#xF3;ticos</article-title>
          <source>Rev Bras Med</source>
          <year>2012</year>
          <volume>69</volume>
          <fpage>24</fpage>
          <lpage>27</lpage>
        </element-citation>
      </ref>
      <ref id="r08">
        <label>8</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ferraz</surname>
              <given-names>HB</given-names>
            </name>
          </person-group>
          <article-title>Tratamento da Doen&#xE7;a de Parkinson</article-title>
          <source>Rev Neuroci&#xEA;ncias</source>
          <year>1999</year>
          <volume>7</volume>
          <fpage>6</fpage>
          <lpage>12</lpage>
        </element-citation>
      </ref>
      <ref id="r09">
        <label>9</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Vollum</surname>
              <given-names>DI</given-names>
            </name>
            <name>
              <surname>Parkes</surname>
              <given-names>JD</given-names>
            </name>
            <name>
              <surname>Doyle</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
          <article-title>Livedo Reticularis during Amantadine Treatment</article-title>
          <source>Br Med J</source>
          <year>1971</year>
          <volume>2</volume>
          <fpage>627</fpage>
          <lpage>628</lpage>
          <pub-id pub-id-type="pmid">5580722</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
